Latest News about Preclinical Phase
Recent news which mentions Preclinical Phase
EXCLUSIVE: SAB Biotherapeutics' Type 1 Diabetes Candidate Moves One Step Closer To Enter Human Trials With Completion Of Toxicology Study
January 10, 2023
Tickers
SABS
From Benzinga
Revelation Biosciences Stock Soars After Encouraging Preclinical Data From Kidney Disease Candidate
October 25, 2022
Tickers
REVB
From Benzinga
Solid Biosciences Touts Encouraging Preclinical Data From Potential Duchenne Gene Therapy
October 17, 2022
Tickers
SLDB
From Benzinga
Adial Pharma Touts Positive Preclinical Data From Chronic Pain Candidate
September 26, 2022
Tickers
ADIL
From Benzinga
Gain Therapeutics Touts Additional Encouraging Preclinical Data For Lead Parkinson's Program
September 26, 2022
Tickers
GANX
From Benzinga
Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection
September 19, 2022
Tickers
BEAM
From Benzinga
Verve Therapeutics Posts Updated Preclinical Data For Gene-Editing Therapy In Cardiovascular Disease
August 22, 2022
Tickers
VERV
From Benzinga
Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder
August 12, 2022
Tickers
FIXX
From Benzinga
Vaxxinity's Vaccine Candidate Shows Durable Cholesterol Lowering Activity In Animal Models
August 02, 2022
Tickers
VAXX
From Benzinga
Hoth Therapeutics Shares Surge On Encouraging Preclinical Data From Alzheimer's Program
July 12, 2022
Tickers
HOTH
From Benzinga
Keros Therapeutics Posts Encouraging Preclinical Data Of RKER-012 In Type Of High Blood Pressure
May 18, 2022
Tickers
KROS
From Benzinga
Phio Pharma's New Preclinical Data Shows PH-894 Enhances Activity of Cancer CAR-T Cells
May 16, 2022
Tickers
PHIO
From Benzinga
Dynavax's Adjuvant-Based Bivalent COVID-19 Vaccine Candidate Shows Encouraging Preclinical Action
May 05, 2022
Tickers
DVAX
From Benzinga
Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains
April 21, 2022
Tickers
CLSN
From Benzinga
Codiak BioSciences's Pan Beta-Coronavirus Vaccine Shows Encouraging Action In Animal Studies
April 21, 2022
Tickers
CDAK
From Benzinga
Artelo Shares Jump On Favorable Preclinical Data In Cancer-Related Muscle-Wasting Syndrome
April 13, 2022
Tickers
ARTL
From Benzinga
Deciphera's DCC-3116/KRAS Inhibitor Combo Shows Deeper, Longer Tumor Regressions In Preclinical Studies
April 13, 2022
From Benzinga
Qualigen Surges 80% As QN-302 Shows Potential Preclinical Mechanism Of Action Against Prostate, Pancreatic Cancers
April 12, 2022
Tickers
QLGN
From Benzinga
Schrödinger New Preclinical Data Supports Development Of Its Wee1 Inhibitor In Cancer Indications
April 12, 2022
Tickers
SDGR
From Benzinga
Lixte Biotech Shares Jumps Over 100% On Promising Preclinical Data From Lead Program In KRAS-Mutant Cancers
April 12, 2022
Tickers
LIXT
From Benzinga
Nanobiotix's Radiotherapy Combo Therapy Shows Boosted Anti-Tumor Activity In Preclinical Studies
April 12, 2022
Tickers
NBTX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|